Clinical management of psoriasis patients during the COVID-19 pandemic.

Chat, Vipawee S; Uppal, Shelley K; Kearns, Donovan G; Wu, Jashin J

Chat, Vipawee S; Uppal, Shelley K; Kearns, Donovan G; Wu, Jashin J.

Afiliação

Chat VS; Medical College of Georgia, Augusta University, Augusta, GA, USA.
Uppal SK; Albany Medical College, Albany, NY, USA.
Kearns DG; Loma Linda School of Medicine, Loma Linda University, Loma Linda, CA, USA.
Wu JJ; Dermatology Research and Education Foundation, Irvine, CA, USA.

J Dermatolog Treat ; 33(2): 1166-1167, 2022 Mar.

Article em En | MEDLINE | ID: mdl-32568009

ABSTRACT

ABSTRACT

Psoriasis is a systemic immune-mediated inflammatory disease that requires consistent treatment and follow-up. Given that COVID-19 will persist in the coming years, dermatologists need to adjust their practices accordingly to care for their patients, particularly psoriasis patients managed with systemic therapies. We provide guidelines for optimizing care for psoriasis patients, including considerations for medication management, lifestyle adjustments, and utilization of telemedicine.

Assuntos

Produtos Biológicos; COVID-19; Psoríase; Telemedicina; Produtos Biológicos/uso terapêutico; Humanos; Pandemias; Psoríase/tratamento farmacológico; Psoríase/epidemiologia; SARS-CoV-2

Palavras-chave

COVID-19; Psoriasis; biological products/therapeutic use; biologics; coronavirus; dermatologic agents/therapeutic use; management; pandemic; telemedicine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos / Telemedicina / COVID-19 Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Dermatolog Treat Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google